International-Accounting-open- Access -Articles G
International
Accounting Standards (IAS) square measure older
accounting standards issued by the International
Accounting Standards Board (IASB), an independent international standard-setting body based in London. The IAS were replaced in 2001 by International money reportage Standards (IFRS). International
Accounting Standards (IAS) were the first international
accounting standards that were issued by the International
Accounting Standards Committee (IASC), formed in 1973. The goal then, as it remains today, was to form it easier to check
businesses round the world, increase transparency and trust in financial reporting, and foster world
trade and investment. Globally comparable
accounting standards promote transparency, accountability, and efficiency in financial markets round the world. This enables investors and different market participants to make informed economic decisions about investment opportunities and risks and improves capital allocation. Universal standards also significantly reduce reporting and regulatory costs, especially for firms with international operations and subsidiaries in multiple countries. There has been vital progress towards developing a single set of high-quality world
accounting standards since the IASC was replaced by the IASB. IFRS are adopted by the ecu Union, leaving the United States, Japan (where voluntary adoption is allowed), ANd China (which says it's working towards IFRS) because the only major
capital markets without an IFRS mandate. As of 2018, 144 jurisdictions required the use of IFRS for all or most publicly listed companies, and a further 12 jurisdictions permit its use.
High Impact List of Articles
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of Clostridium difficile infection: recent trial results
Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
-
Hepatitis B needle-free vaccines: a step closer
Olga Borges, Gerrit Borchard
Editorial: Clinical Investigation
Relevant Topics in Clinical